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I would like to address my attention to the Cancer Program as seen by the basic
science community, not so much in terms of dollars and cents but ofthe objectives;
i.e., where and how the basic sciences should fit and what role they have been asked
to play in the Program. I am not going to deal with specifics ofappropriation from
the NCI budget, nor with the scientific basis of cancer control.
Whatever position one takes with respect to the proper balance of effort in the
Cancer Program toward basic and clinical initiatives, we must recognize that cancer
is a by-product of our technologic society. We are faced with an overwhelming
exposure throughout life to a growing battery ofchemicals. Some estimates are that
perhaps 20,000 new compounds are introduced into potential contact with human
beings each year. The individual compounds would themselves pose a serious threat
of recognition and detection. What then can we take to be the prospects for discern-
ing the limits or effects of the interaction ofa multitude ofchemicals that we breathe,
smoke, eat, drink, wash ourselves with, clothe ourselves in? There is no doubt that 5,
10, 15 or 30 years of post-World War II life has made of all of us chemical reaction
flasks in which the reagents at work are largely unknown or if the reagents are
known, the reactions in which they are critically involved cannot be specified. As
important as the detection and elimination of these carcinogens from the environ-
ment are and must be, the diagnosis and treatment of cancer as well as prevention
aimed at more than the study of chemical carcinogens must be pursued with unrelen-
ting vigor. Cancer is already occurring via these chemicals and intervention looms as
the principal instrument of effective modulation for some decades to come for all
those already subjected to these carcinogens.
Malignancies of all classes share in common the basic property that the malignant
cells have lost contact with control devices in the host animal. Those devices serve to
achieve the balanced functioning of the body. Malignant cells grow without respect
for the limits set by the body for organ size or production of hormones or other
pharmacologically active molecules by specific cells. The invasion ofadjacent tissues,
attachment to set up a focus of new growth in distant organs and vessels, special
products which are released from the tumor cells, and the unequal competition for
nutrients established by the colony of malignant cells are the features that constitute
the threat and the ultimate destructive force of a cancer or malignant tumor.
Investigators in the biomedical sciences who have dedicated their lives to the most
fundamental studies of biologic phenomena, which have led to the development of
current anti-tumor therapy and newer methods ofdetection ofchemical carcinogens,
fear that the Cancer Program has focused on the transmission ofexisting knowledge
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Part ofthat fear is engendered by the awareness ofscientists throughout the country
in all scientific disciplines that the highest echelons of government seem to have
accepted the notion that managerial initiatives can solve any problem. Scientists
recognize that money can buy impressive tables of organization with a body at every
desk without making serious strides toward even the recognition ofthe real state of
knowledge. Every effort must therefore be made to expose the inner workings of a
program to scrutiny by the several publics including the scientists. These internal
administrative and managerial issues have been carefully and effectively planned for
in the Cancer Program and it is the most critical assignment of the Panel, the
Advisory Board, and the Director of NCI to address these problems.
Biomedical science has as its ultimate objective clarification (in the most finite
detail) of the normal functioning of cells, much of which is understood through
abnormal conditions. Mutations, used to delete a normal enzyme or other product,
thus creating an abnormal state, provided one of the principal biologic tools for the
study of normal DNA synthesis, protein synthesis, vitamin utilization and energy
production. Abnormal conditions occurring spontaneously in nature have proved
equally important for the study of normal processes, e.g., diabetes and normal sugar
metabolism, hemoglobin abnormalities and protein structure and genetics. Basic
scientists working in the biological and biomedical sciences have no quarrel with the
ultimate objective of early recognition of the abnormal by understanding of the
normal. Beyond that they are also concerned with prevention, cure, or arresting the
progress of abnormal conditions. What the basic scientist fears most is that a
program based upon false assumptions will apply the long range goal unwisely to the
immediate project in which he is engaged. Such application imposes justifications,
requires proof of legitimacy, preselects the observation the investigator can pursue,
and determines to what degree those observations may be pursued. Thus the long
range goal-prevention and cure-can become a corrosive criterion underminingthe
most fertile initiatives for lack of program relevance.
All investigators in the biological sciences are agreed that serendipity is their most
valuable ally. What emerges unexpectedly in experiments is often the most critical
information obtained in the experiment and those findings are especially pertinent to
new directions in approach and understanding, throwing new light on old questions.
It is imperative that the state of mind of the investigator be such as to perceive the
unexpected for what it may ultimately be worth. Program relevance dictates a
selection in registering of observations that may categorize as worse than useless a
contradictory finding.
The Cancer Program as such came into being from recognition by national figures
with a long-term interest in the cancer problem that much of what was being
accomplished in experimental laboratories around the world did not reach clinicians
and was unlikely to benefit cancer patients in the nearfuture unless aspecial national
effort were mounted. The proponents of this plan were no doubt correct in their
appraisal. And it must be admitted that the basic scientists were not prominent
among those who were aware of the dilemma nor among those who spearheaded
presentations before the Congress. In fact, many are agreed that the timing was
astute; the Cancer Program was conceived and its backers strongly influenced by the
insights into biologic regulation and control produced between 1945 and 1970 by
molecular biologists and geneticists the world over. Who would have disagreed that
the time was ripe for applying that fundamental knowledge to a problem defined as
one of regulation or control gone haywire, cancer?
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Unfortunately, the specific events leading to malignant behavior on the part of a
cell are not yet in any fundamental way understood. What we do know is that
radiation, chemicals and viruses with varying degrees of complicity can cause cancer
in experimental animals. It is probable that the final trigger is the same though that is
by no means certain. Many naturally occurring cancers in man come to the final
malignant state only after 15 to 20 years of recognizable premalignant state. Every-
where there are thresholds but no threshold has yet been crossed and there is no
indication at present what is likely to prove crucial. Therefore, the Program must be
basic in its conception of what objectives are to be applied and where none are to be
assigned.
The Cancer Program has, in my opinion, demonstrated from its inception a
commitment to supporting the research proposals of investigators of the highest
quality without reference to relevance by a program-limited definition of relevance.
With the encouragement of the Cancer Panel headed by Mr. Schmidt and the
Advisory Board chaired by Dr. Rhoads, greater emphasis has been directed to
investigator-initiated research, as witnessed by an increasing proportion of allotted
funds being spent and to be spent in projected budgets for fiscal '78, '79, and '80 on
investigator-initiated proposals. Perhaps equally as significant, the definition and
management of basic research accomplished by contract agreement have been liberal-
ized to allow freedom of pursuit by the investigator. Of equal importance, measures
have been initiated in all Divisions of NCI to implement stricter peer review in all
contract agreements for basic research. No one involved in policy decisions in the
Cancer Program would deny that the problem of the support ofbasic research in the
total Health Program remains unresolved. In my opinion, solutions involve increased
fund allotments in the total Health Program for untargeted research. The current
state of our ignorance of fundamental human biological processes should make
evident that this reality cannot be denied.
The Cancer Program has proposed and increasingly supported the most basic of
research program projects and research grants in immunology, virology, cell biology,
bacterial metabolism, DNA synthesis, bacteriophage assembly, protein structure,
carbohydrate chemistry and biochemistry. It has sought to enlist the most perceptive
and creative biological, biophysical, and biochemical minds in areas of fundamental
cancer biology. It is my hope to convince our most gifted and productive scientists, of
all levels of experience, to devote some fraction of their time to the intriguing and
vexing problems of the induction of malignancy, its early detection, its prevention
and therapy. The program from the start envisaged a fundamental role for basic
science going even so far as to create basic science centers as specialized centers and
making mandatory a basic science component of every Comprehensive Center. The
basic sciences have been and are still being asked to play a focal role in the Program
and in advising all segments of the Program at the level ofthe science they could and
should undertake. It is perhaps the diversity of the basic science involvement, with
the lack of an identifiable basic science program segment, that has misled the basic
science community into believing that its role is limited and secondary.
Because the Cancer Program's commitment to basic research is long standing and
explicit and has developed as a model for future initiatives, new and imaginative steps
are in order. It is essential that every encouragement be given to worthy new ideas, no
matter how unconventional they may be. The criteria of scientific competence and
originality should warrant a significant thrust toward the support of exciting propo-
sals with a high risk factor. To accomplish this, I would propose a specific program to
fund "high excitement ideas" of broadly defined merit. These would have task force
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Committee of NCI with funding authority.
There is a second critical need as I see it in the basic science area. It is for a modest
number of5- to 10-year grants to talented young investigators to allow them to attack
problems of major scientific and program value that will not necessarily yield the
required number of research papers per year at the outset. Too much pressure is put
on the young to choose research areas of high data yield. The progress of work on
these grants-of a sum sufficient to permit serious research-would be followed by a
special committee, with a view to assisting wherever possible the investigator in the
resolution of difficult areas of his project. If basic science is to maintain its import-
ance as the frontier of unexplored domains, breakpoint funds for the calculated
adventure must be assured. An understanding of the biology ofdiseases long in the
making in an ecologic sense, will require a burst of new and radical ideas that we
cannot hope to generate without inviting our most gifted individuals to the freest
inquiry.
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